Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could the flow of anesthesia gas affect your memory after surgery?

NCT ID NCT07212543

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how different low-flow rates of the anesthesia gas desflurane affect brain activity and thinking skills in adults having major abdominal surgery. Researchers will monitor brain waves during surgery and test memory and attention within 24 hours after the operation. The goal is to find out which low-flow strategy is safest for mental recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
desflurane
What this could lead to
If successful, this could help anesthesiologists choose safer low-flow anesthesia settings that preserve patients' memory and attention after major surgery.
What could go wrong
This is a small, early-stage study with only 72 participants, so results may not apply to all patients. It looks at short-term cognitive changes, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

72 people

The number who actually took part.

Started

May 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will be recruited from patients undergoing elective major abdominal surgery at the Department of Anesthesiology and Reanimation, Ankara Dr Abdurrahman Yurtaslan Onkology Training and Research Hospital.

Ages

18 to 75 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients aged 18-75 years ASA physical status I-III Scheduled for elective major abdominal surgery Provided written informed consent Normal preoperative neurocognitive function Exclusion Criteria: History of neurological or psychiatric disorders History of cognitive impairment Diagnosed hepatic or renal insufficiency Presence of other systemic diseases contraindicating anesthesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Major abdominal surgeries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital

    Ankara, YENİMAHALLE, 06200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.